Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2001-04-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.081620098PMCID PMC33303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Statins and the risk of dementia.

  2000cited by this paper
• Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

  2000cited by this paper
• Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

  2000cited by this paper
• Molecular genetics of Alzheimer's disease.

  2000cited by this paper
• Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state.

  2000cited by this paper
• A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood.

  1999cited by this paper
• Comparative regulation of hepatic sterol 27-hydroxylase and cholesterol 7alpha-hydroxylase activities in the rat, guinea pig, and rabbit: effects of cholesterol and bile acids.

  1999cited by this paper
• The role of cholesterol in the biosynthesis of beta-amyloid.

  1999cited by this paper
• Intracellular biology of Alzheimer’s disease amyloid beta peptide

  1999cited by this paper
• Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase.

  1999cited by this paper
• Quantification of Alzheimer Amyloid Peptides Ending at Residues 40 and 42 by Novel ELISA Systems

  1999cited by this paper
• Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

  1998cited by this paper
• Cholesterol-dependent generation of a unique amyloid beta-protein from apically missorted amyloid precursor protein in MDCK cells.

  1998cited by this paper
• Influence of lipid profile and fatty acid composition on the oxidation behavior of rat and guinea pig low density lipoprotein.

  1998cited by this paper
• Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons.

  1998cited by this paper
• βAPP γ‐secretase and SREBP site 2 protease are two different enzymes

  1998cited by this paper
• Cerebral changes and cerebrospinal fluid β-amyloid in Alzheimer's disease: a study with quantitative magnetic resonance imaging

  1997cited by this paper
• Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells

  1997cited by this paper
• Functional rafts in cell membranes

  1997cited by this paper
• Intracellular and secreted Alzheimer beta-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons.

  1997cited by this paper
• Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition

  1997cited by this paper
• Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study.

  1997cited by this paper
• Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42*

  1997cited by this paper
• Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides

  1997cited by this paper
• Alzheimer's Disease βA4 Protein Release and Amyloid Precursor Protein Sorting Are Regulated by Alternative Splicing*

  1996cited by this paper
• Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.

  1996cited by this paper
• The beta‐amyloid domain is essential for axonal sorting of amyloid precursor protein.

  1996cited by this paper
• Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

  1996cited by this paper
• Intracellular Trafficking of Cholesterol Monitored with a Cyclodextrin*

  1996cited by this paper
• Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay*

  1996cited by this paper
• Amyloids and Are Generated Intracellularly in Cultured Human Neurons and Their Secretion Increases with Maturation (*)

  1996cited by this paper
• Evidence that Aβ42 is the real culprit in alzheimer's disease

  1995cited by this paper
• Production of intracellular amyloid‐containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence.

  1995cited by this paper
• Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.

  1994cited by this paper
• Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol

  1994cited by this paper
• Scandinavian simvastatin study (4S)

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides.

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

  1992cited by this paper
• Amyloid β-peptide is produced by cultured cells during normal metabolism

  1992cited by this paper
• A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans.

  1991cited by this paper
• Biochemical changes and morphological alterations of the liver in guinea-pigs after administration of simvastatin (HMG CoA reductase-inhibitor).

  1990cited by this paper
• Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population.

  1990cited by this paper
• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper
• Cell Cycle‐Specific Requirement for Mevalonate, but Not for Cholesterol, for DNA Synthesis in Glial Primary Cultures

  1987cited by this paper
• Hypocholesteremia induced by orotic acid: dietary effects and species specificity.

  1984cited by this paper
• The density profile and cholesterol concentration of serum lipoproteins in domestic and laboratory animals.

  1982cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957cited by this paper

• Impact of statins on mortality and disease progression in patients with Alzheimer's disease: a nationwide cohort study.

  2025cites this paper
• Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management

  2025cites this paper
• Statin is associated with higher cortical thickness in early Alzheimer's disease.

  2025cites this paper
• Rho GTPases, a Potential Target for the Treatment of Neurodegenerative Disorders and the Neuroprotective Effect of Statins as a Rho GTPase Inhibitor

  2025cites this paper
• Targeting autophagy in astrocytes: a potential for neurodegenerative disease intervention

  2025cites this paper
• Lipid Metabolism and Statin Therapy in Neurodegenerative Diseases: An Endocrine View

  2025cites this paper
• Amyloid β1‐40 Predicts Long‐Term Mortality Rate in Patients With Acute Myocardial Infarction

  2025cites this paper
• Inhibition of NMDA receptors and other ion channel types by membrane-associated drugs

  2025cites this paper
• Unraveling the role of brain renin angiotensin system in vascular dementia: mechanisms and therapeutic perspectives

  2025cites this paper
• Target the Heart: A New Axis of Alzheimer’s Disease Prevention

  2025cites this paper
• The relationship between trajectories of serum lipids and cognitive impairment in middle aged and elderly: A 6-year prospective cohort study in Xi'an, China.

  2025cites this paper
• Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications

  2025cites this paper
• New insight into the role of altered brain cholesterol metabolism in the pathogenesis of AD: a unifying cholesterol hypothesis and new therapeutic approach for AD.

  2025cites this paper
• Simvastatin, Its Antimicrobial Activity and Its Prevention of Alzheimer’s Disease

  2024cites this paper
• Alzheimer’s Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models)

  2024cites this paper
• The role of ATP‐binding cassette transporter G1 (ABCG1) in Alzheimer's disease: A review of the mechanisms

  2024cites this paper
• Unveiling the impact of Aging on BBB and Alzheimer's disease: Factors and Therapeutic implications.

  2024cites this paper
• Professor Klaus Fassbender: The Father of Mobile Stroke Units

  2024cites this paper
• Future Directions in Therapies for Acute Respiratory Distress Syndrome.

  2024cites this paper
• HMG-CoA reductase inhibitor simvastatin ameliorates trimethyltin neurotoxicity and cognitive impairment through reversal of Alzheimer’s-associated markers

  2024cites this paper
• Biomarkers of Importance in Monitoring Heart Condition After Acute Myocardial Infarction

  2024cites this paper
• Therapeutic potential of Simvastatin and Doxycycline combination for Alzheimer’s disease

  2024cites this paper
• Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging

  2024cites this paper
• Mapping the lipidome in mitochondria‐associated membranes (MAMs) in an in vitro model of Alzheimer's disease

  2024cites this paper
• Alzheimer’s disease risk reduction in clinical practice: a priority in the emerging field of preventive neurology

  2024cites this paper
• Association of Statin Use with Dementia Risk Among Older Adults in Japan: A Nested Case-Control Study Using the LIFE Study

  2024cites this paper
• Neuroprotective effect of ropinirole against Aβ1–42 ‐induced neurochemical perturbations and cognitive impairments in a rodent model

  2023cites this paper
• Correlations between the NMR Lipoprotein Profile, APOE Genotype, and Cholesterol Efflux Capacity of Fasting Plasma from Cognitively Healthy Elderly Adults

  2023cites this paper
• Enhanced Neuroprotective Synergy of Atorvastatin and Magnesium L-Threonate in a Rat Model of Alzheimer’s Disease Induced by Aluminum Chloride

  2023cites this paper
• The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action

  2023cites this paper
• Cholesterol-dependent amyloid β production: space for multifarious interactions between amyloid precursor protein, secretases, and cholesterol

  2023cites this paper
• Protective Effects of Statins against Alzheimer Disease

  2023cites this paper
• A Review on Phyto-Therapeutic Approaches in Alzheimer’s Disease

  2023cites this paper
• Neuronal γ-secretase regulates lipid metabolism, linking cholesterol to synaptic dysfunction in Alzheimer's disease.

  2023cites this paper
• Cholesterol twists the transmembrane Di-Gly region of amyloid-precursor protein

  2023cites this paper
• Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy

  2023cites this paper
• Acute ACAT1/SOAT1 Blockade Increases MAM Cholesterol and Strengthens ER-Mitochondria Connectivity

  2023cites this paper
• The efficacy of statins for improving cognitive impairments in pediatric patients with neurofibromatosis type 1 (NF-1): a meta-analysis

  2023cites this paper
• Proteomic Analysis Reveals Potential Exosomal Biomarkers in Patients With Sporadic Alzheimer Disease

  2023cites this paper
• Protective Effects Against Dementia Undergo Different Statin Type, Intensity, and Cumulative Dose in Older Adult Type 2 Diabetes Mellitus Patients.

  2023cites this paper
• Cellular cholesterol loss by DHCR24 knockdown leads to Aβ production by changing APP intracellular localization

  2023cites this paper
• Human mini-brains for reconstituting central nervous system disorders.

  2023cites this paper
• Cholesterol, Amyloid Beta, Fructose, and LPS Influence ROS and ATP Concentrations and the Phagocytic Capacity of HMC3 Human Microglia Cell Line

  2023cites this paper
• N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases

  2022cites this paper
• Guanabenz mitigates the neuropathological alterations and cell death in Alzheimer’s disease

  2022cites this paper
• Mechanistic Link between Vitamin B12 and Alzheimer’s Disease

  2022cites this paper
• Potential Value of Serum Lipid in the Identication of Postoperative Delirium Undergoing Knee/Hip Arthroplasty: The Perioperative Neurocognitive Disorder and Biomarker Lifestyle Study

  2022cites this paper
• Effects of Simvastatin on Plasma Amyloid-β Transport in Patients with Hyperlipidemia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial

  2022cites this paper
• Two statins and cromolyn as possible drugs against the cytotoxicity of Aβ(31–35) and Aβ(25–35) peptides: a comparative study by advanced computer simulation methods

  2022cites this paper
• Interdisciplinary Approaches to Deal with Alzheimer’s Disease—From Bench to Bedside: What Feasible Options Do Already Exist Today?

  2022cites this paper
• Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review

  2022cites this paper
• Diverse Roles of Ceramide in the Progression and Pathogenesis of Alzheimer’s Disease

  2022cites this paper
• Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer’s disease

  2022cites this paper
• Prion therapeutics: Lessons from the past

  2022cites this paper
• Effect of Cholesterol on C99 Dimerization: Revealed by Molecular Dynamics Simulations

  2022cites this paper
• Decreased pH in the aging brain and Alzheimer's disease.

  2021cites this paper
• An evidence-based review of neuronal cholesterol role in dementia and statins as a pharmacotherapy in reducing risk of dementia

  2021cites this paper
• Phytosterols: Potential Metabolic Modulators in Neurodegenerative Diseases

  2021cites this paper
• Intranasal gene therapy for the treatment of neurological disorders

  2021cites this paper
• Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases

  2021cites this paper
• Blood Triglyceride and High-Density Lipoprotein Levels Are Associated with Plasma Amyloid-β Transport: A Population-Based Cross-Sectional Study

  2021cites this paper
• In Silico Insights of Tunable Small Molecules With Regulatory Activity of Acid Sphingomyelinase-Protein Kinase Cδ Interaction

  2021cites this paper
• Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids

  2021cites this paper
• Serum Metabolites Differentiate Amnestic Mild Cognitive Impairment From Healthy Controls and Predict Early Alzheimer's Disease via Untargeted Lipidomics Analysis

  2021cites this paper
• The Effects of Statins on Neurotransmission and Their Neuroprotective Role in Neurological and Psychiatric Disorders

  2021cites this paper
• Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer's pathology: Insights and therapeutic approaches from periphery.

  2021cites this paper
• Association between statin use and Alzheimer’s disease with dose response relationship

  2021cites this paper
• An Analysis of the Neurological and Molecular Alterations Underlying the Pathogenesis of Alzheimer’s Disease

  2021cites this paper
• Endosomal‐lysosomal dysfunctions in Alzheimer’s disease: Pathogenesis and therapeutic interventions

  2021cites this paper
• Role of Natural Products for the Treatment of Alzheimer's Disease.

  2021cites this paper
• Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets

  2021cites this paper
• Mitochondrial associated ER membrane (MAM) compartment and its dysregulation in Amyotrophic lateral sclerosis (ALS).

  2021cites this paper
• Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice

  2021cites this paper
• Neurodegenerative Diseases and Cholesterol: Seeing the Field Through the Players

  2021cites this paper
• Validation of Ganoderma lucidum against hypercholesterolemia and Alzheimer's disease

  2020cites this paper
• Effect of C-terminus amidation of Aβ39–42 fragment derived peptides as potential inhibitors of Aβ aggregation

  2020cites this paper
• Relationship Between Genetic Variants of ACAT1 and APOE with the Susceptibility to Dementia (SADEM Study)

  2020cites this paper
• A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy

  2020cites this paper
• Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer’s Disease Patients and Correlates with Cognitive Performance

  2020cites this paper
• Boosting the autophagy‐lysosomal pathway by phytochemicals: A potential therapeutic strategy against Alzheimer's disease

  2020cites this paper
• Nutrient signaling pathways regulate amyloid clearance and synaptic loss in Alzheimer’s disease

  2020cites this paper
• Treating Alzheimer’s disease pathology: Present to alternative modalities

  2020cites this paper
• The Alzheimer’s Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease

  2020cites this paper
• Benefits and Harms of Statins in People with Dementia: A Systematic Review and Meta‐Analysis

  2020cites this paper
• Beneficial association of angiotensin-converting enzyme inhibitors and statins on the occurrence of possible Alzheimer’s disease after traumatic brain injury

  2020cites this paper
• Cellular and molecular mechanisms of curcumin in prevention and treatment of disease

  2020cites this paper
• Brain Aging, Cardiovascular Diseases, Mixed Dementia, and Frailty in the Oldest Old: From Brain Phenotype to Clinical Expression

  2020cites this paper
• Association of blood lipids, atherosclerosis and statin use with dementia and cognitive impairment after stroke: a systematic review and meta-analysis.

  2020cites this paper
• Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol

  2020cites this paper
• Effect of pioglitazone and simvastatin in lipopolysaccharide-induced amyloidogenesis and cognitive impairment in mice: possible role of glutamatergic pathway and oxidative stress

  2019cites this paper
• Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine.

  2019cites this paper
• Profiling of Alzheimer's disease related genes in mild to moderate vitamin D hypovitaminosis.

  2019cites this paper
• Aging membranes: Unexplored functions for lipids in the lifespan of the central nervous system.

  2019cites this paper
• Dietary Sargassum fusiforme improves memory and reduces amyloid plaque load in an Alzheimer’s disease mouse model

  2019cites this paper
• Prostaglandin A1 Inhibits the Cognitive Decline of APP/PS1 Transgenic Mice via PPARγ/ABCA1-dependent Cholesterol Efflux Mechanisms

  2019cites this paper
• Lipid metabolism in Alzheimer's disease.

  2019cites this paper
• Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies.

  2019cites this paper
• Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease

  2019cites this paper
• ACAT1 as a therapeutic target and its genetic relationship with Alzheimer's disease.

  2019cites this paper
• Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer’s disease: A genetic and proteomic multi-cohort study

  2019cites this paper